Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Reviews
Search Article 
  
Advanced search 
 


 
 Table of Contents  
REVIEW ARTICLE
Year : 2015  |  Volume : 9  |  Issue : 17  |  Page : 19-23  

Occurrence of taraxerol and taraxasterol in medicinal plants


Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

Date of Submission06-Apr-2014
Date of Acceptance25-May-2014
Date of Web Publication05-May-2015

Correspondence Address:
Prof. Rasheeduz Zafar
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jamia Hamdard, New Delhi - 110 062
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-7847.156317

Rights and Permissions
   Abstract 

Indian soil germinates thousands of medicinal drugs that are cultivated with a purpose to obtain a novel drug. As it is a well-established fact that the structural analogs with greater pharmacological activity and fewer side-effects may be generated by the molecular modification of the functional groups of such lead compounds. This review throws light on two natural triterpenes - Taraxerol and Taraxasterol which have many important pharmacological actions including anti-cancer activity, their chemistry, biosynthesis aspects, and possible use of these compounds as drugs in treatment of cancer. A silent crisis persists in cancer treatment in developing countries, and it is intensifying every year. Although at least 50-60% of cancer victims can benefit from radiotherapy that destroys cancerous tumors, but search for the paramount therapy which will prove to be inexpensive with minimal side effects still persists. Various treatment modalities have been prescribed, along with conventional and non-conventional medicine but due to their adverse effects and dissatisfaction among users, these treatments are not satisfactory enough to give relief to patients. Hence, this review sparks the occurrence of Taraxerol (VI) and Taraxasterol (VII) in nature, so that the natural godowns may be harvested to obtain these potent compounds for novel drug development as well as discusses limitations of these lead compounds progressing clinical trials.

Keywords: Plant tissue culture, taraxerol, taraxasterol


How to cite this article:
Sharma K, Zafar R. Occurrence of taraxerol and taraxasterol in medicinal plants. Phcog Rev 2015;9:19-23

How to cite this URL:
Sharma K, Zafar R. Occurrence of taraxerol and taraxasterol in medicinal plants. Phcog Rev [serial online] 2015 [cited 2019 Jun 17];9:19-23. Available from: http://www.phcogrev.com/text.asp?2015/9/17/19/156317


   Introduction Top


Nowadays, bioactive agents from natural sources are discovered and screened for their therapeutic efficacy. Natural products are known to account for 30% of international drug sales. Although most of the medicines are derived from terrestrial plants and animals, ecologists estimate the number of the species in the marine environment to be 0.5-10 million. [1] Most of these are still on the verge to be discovered. Well, that may be the reason behind therapeutic efficacy of natural products being predominantly achieved in antibiotic therapies, oncology, and immune regulation. Natural products are generally not related to the biological environment of the producing organism, henceforth it is less likely to identify potent natural products against molecular targets. Furthermore, higher hit rates are generally obtained for natural product libraries in high throughput screening campaigns (HTS) compared to medchem or combichem libraries. Certainly, natural products are a valuable source of unsurpassed structural diversity and functional density to identify screening hits. After a long period, natural products drug discovery has again gained attention. Also, World Health Organization (WHO) has been promoting traditional medicines as a source of less expensive, comprehensive medical care, especially in developing countries. However, despite the promise of these alternative drug discovery methods, there is still a shortage of lead compounds progressing into the clinical trials. This is specially the case in therapeutic areas such as oncology, immunosuppression, and metabolic diseases where natural products have played a central role in drug discovery.


   Biosynthetic aspects Top


The biosynthesis of taraxerol (VI) is same up to formation of squalene to (3S)-2, 3-epoxy-2, 3-dihydrosqualene biosynthesis as in the biosynthesis scheme of triterpenes by enzymes oxidosqualene cyclases. After this, (3S)-2, 3-epoxy-2, 3-dihydrosqualene gets converted to olean-13-yl cation, which is further converted to taraxerol by the action of enzyme taraxerol synthase Systematic name: (3S)-2, 3-epoxy-2, 3-dihydrosqualene mutase (cyclizing, taraxerol-forming). The enzyme gives taraxerol, β-amyrin, and lupeol in the ratio 70:17:13. Also the olean-13-yl cation undergoes a series of rearrangement reactions to give isomultifluorenol, Ψ taraxasterol, and taraxasterol (VII) [Figure 1]. [2]
Figure 1: Biosynthetic pathways followed by Taraxasterol and Taraxasterol: Sqaualene act as a precursor molecule lead to formation of (3S)-2, 3-epoxy-2, 3-dihydrosqualene (I), dammarenyl cation (II), baccharenyl cation (III), lupanyl cation (IV), and olean-19-yl-cation (V), olean-19-yl-cation further forms taraxerol (VI), taraxasterol (VII), iso-mumultiflurenol (VIII), glutinol (IX), and friedelin (X)

Click here to view


Chemistry

The CAS name of Taraxerol, [Figure 2]a is (3b)- D-Friedoolean-14-en-3-ol. Its additional names include isoolean-14-en-3b-ol, skimmiol, alnulin, tiliadin. Its molecular formula is C 30 H 50 O and molecular weight is 426.72. Its melting point is 282-285°C. Its structure was given by Beaton et al.[3] The CAS name of Taraxasterol, [Figure 2]b is (3b, 18a, 19a)-Urs-20 (30)-en-3-ol. Its molecular formula is C 30 H 50 O and molecular weight is 426.72 same as Taraxerol. Its structure and configuration was reported by Ames et al.[4] The insecticidally inactive substance pyrethrol from pyrethrum flowers has been identified as taraxasterol. [5] Both Taraxerol and Taraxasterol were investigated by high-performance liquid chromatography (HPLC) using methanol containing 0.1% phosphoric acid. [6] A simple and precise high-performance thin layer chromatography (HPTLC) method has been developed for estimation of Taraxerol with hexane and ethyl acetate (80:20 v/v), using visualizing agent anisaldehyde sulphuric acid, and scanning of plate was done at 420 nm. The system was found to give compact spots for Taraxerol (R f 0.53). [7]
Figure 2: (a) Structure of Taraxerol (3β)-D-Friedoolean-14-en- 3ol) (b) Structure of Taraxasterol (3β, 18α, 19α)-Urs- 20(30)-en-3-ol)

Click here to view


Pharmacological actions

Taraxerol and taraxasterol are important compounds that possess anti-tumor actions. [8] Taraxerol showed significant anti-inflammatory activity in albino rats as well as anti-cancer activity against sarcoma 180 cell line in mice. [9] Both compounds showed remarkable inhibitory effect on mouse spontaneous mammary tumors. [10] Triterpenes are also known to augment the inhibitory effects of anti-cancer drugs. [11] Also it has been known to benefit in Alzhiemer's and Parkinsonism. [12] Taraxerol is known to induce apoptosis, COX inhibitor, [13] acetyl cholinesterase inhibitor, [14] and possess anti-microbial potential. [15] Taraxasterol is anti-allergic, [16] anti-oxidant, [17] and anti-inflammatory. [18] Taraxerol is also known to benefit in diabetes. [19] Both the compounds are also known to exhibit activity against snake venom. [20] [Table 1], below, enlists medicinal plants containing taraxerol and taraxasterol.
Table 1: List of medicinal plants containing taraxerol and taraxasterol


Click here to view



   Limitations and future prospects Top


Although there are many lead compounds with promising potential for cancer therapy, the cytotoxicity would itself become a constraint for this because most of these compounds could be cytotoxic towards normal cells in addition to the cancerous cells. Various researches have been carried out on both these compound's anti-cancer activity on animal cell lines but further researches must be carried out to find out the effect of these compounds on human cancer cell lines and specificity of these compounds on cancer cells. Also, the research must be carried out to ascertain the possible mechanism of action of both these compounds as no satisfactory data is available for mechanism of anti-cancer activity of these compounds as well as their adverse effects must be also assessed. Therefore, considerable cytotoxicity studies must be conducted employing the lead compounds before introducing them to drug development phase. However, advances in drug delivery systems could be applied effectively in specific delivery of therapeutics. Cancer cells carry specific receptors that are expressed at higher levels than their normal counterparts. Often these receptors have binding affinity towards specific proteins or peptides and these can be used for direct targeting of cancer cells which is effectively applicable to develop targeted delivery systems. Nano drug carriers coated with cancer cell receptor binding factors are novel and effective approach for the targeted delivery of drugs. This method can be used to deliver anti-cancer triterpenols to the cancer tissues and thereby protecting the normal adjacent tissue cells. [48] Moreover, the possibility of continous supply of the product and the ecological importance of the triterpene sources are factors of importance before entering the drug development phase. Sustainable production of these compounds through chemical synthesis or isolation must be ensured. The structural complexities have challenged the chemical synthesis and thus it would be a limitation to the entering of these compounds to the drug development phase. However, with the advances in synthetic chemistry and an understanding of the biosynthetic pathway of triterpenes newer opportunities for exploitation of these compounds as drug leads are opening up. [49]


   Conclusion Top


Plant tissue culture science has recently reported various elite gemplasms which constitutes high amount of therapeutically active compounds then its native form. Lower native concentration of taraxerol and taraxasterol limits its applications in pharmaceutical science. Tissue culture science has successfully explored various germplasms to manipulate the in vitro conditions for elevating the concentration of these compounds in their native form. Anticancer and other potential properties of these compounds attracted tissue culture science to explore various strategies to trigger their concentration and trace their respective pathways for provoking their utilization in the therapeutic world. Optimization/manipulation of in vitro conditions, tracing biosynthetic pathways, elicitation, precursor feeding, immobilization, and genetic manipulation still holds promises in understanding the facts that hinders native synthesis of such biomarker compounds. Nevertheless, of significant challenges remain: Cancer still remains to be a disease of unknown etiology and none of the therapies described represents a cure. It will be interesting to see whether the progress in Indian herbs to generate novel formulation will eventually provide the profound insights required to conquer this condition for the next 25 years.


   Acknowledgement Top


The authors are thankful to CSIR for providing SRF for research work and Prof. Rasheeduz Zafar for providing his valuable guidance.

 
   References Top

1.
Sharma K, Rani R, Dhalwal K, Shinde V, Mahadik KR. Natural compounds as anti-arthritic agents-A Review. Phcog Rev 2009;3:22-8.  Back to cited text no. 1
  Medknow Journal  
2.
Whang Z, Guhling O, Yao R, Li F, Yeats TH, Rose JK, et al. Two oxidosqualene cyclases responsible for biosynthesis of tomato fruit cuticular triterpenoids. Am Soc Plant Biol 2011;155:542-52.  Back to cited text no. 2
    
3.
Beaton JM, Spring FS, Stevenson R, Steward JL. Triterpenoids, part XXXVII: The constitution of Taraxerol. J Chem Soc 1955:2131-7.  Back to cited text no. 3
    
4.
Ames TR, Beaton JL, Bowers A, Halsall TG, Jones ER. Structure and configuration of Taraxasterol. J Chem Soc 1954:1905-19.  Back to cited text no. 4
    
5.
Herz W, Mirrington RN. Identification of pyrethrol with taraxasterol. J Pharm Sci1966;55:104.  Back to cited text no. 5
    
6.
Niemann GJ, Baas WJ. High Performance liquid chromatography of triterpenols. J Chromat Sci 1978;16:260-2.  Back to cited text no. 6
    
7.
Kumar V, Mukherjee K, Kumar S, Mal M, Mukherjee PK. Validation of HPTLC method for the analysis of Taraxerol in Clitorea ternatea. Phytochem Anal 2008;19:244-50.  Back to cited text no. 7
    
8.
Jamshieed S, Das S, Sharma MP, Srivastava PS. Difference in in vitro response and esculin content of Taraxacum officinale Weber. Physiol Mol Biol Plant 2010.  Back to cited text no. 8
    
9.
Biswas M, Biswas K, Ghosh AK, Haldar PK. A pentacyclic triterpenoid possessing anti-inflammatory activity from the fruits of Dregea volubilis. Phcog Mag 2009;5:64-8.  Back to cited text no. 9
  Medknow Journal  
10.
Takasaki M, Konoshima T, Tokuda H, Masuda K, Arai Y, Shiojima K, et al. Anticarcinogenic activity of Taraxacum plant II. Biol Pharm Bull 1999;22:606-10.  Back to cited text no. 10
    
11.
Yamai H, Sawada N, Yoshida K, Seike J, Takizawa H, Kenzaki K, et al. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer 2009;125:952-60.  Back to cited text no. 11
    
12.
Ngo ST, Li MS. Top-leads from natural products for treatment of Alzheimer's disease: Docking and molecular dynamics study. Mol Stim2013;39:279-91.  Back to cited text no. 12
    
13.
Rehman UU, Shah J, Khan MA, Shah MR, Khan I. Molecular docking of taraxerol acetate as a new COX inhibitor. Bangl J Pharmacol2013;8:194-7.  Back to cited text no. 13
    
14.
Kumar V, Mukherjee K, Pal BC, Houghton PJ, Mukherjee PK. Acetylcholinesterase inhibitor from Clitorea ternatea. Planta Medica 2007;73:973-4.  Back to cited text no. 14
    
15.
Singh B, Sahu PM, Sharma MK. Anti-inflammatory and antimicrobial activities of triterpenoids from Stribolanthes Callosus nees. Phytomedicine 2002;9:355-9  Back to cited text no. 15
    
16.
Liu J, Xiong H, Cheng Y, Cui C, Zhang X, Xu L, et al. Effects of taraxasterol on ovaalbumin induced allergy in mice. J Ethnopharmacol 2013;148:787-93.  Back to cited text no. 16
    
17.
Gallova J, Horvathova M, Grancai D. Taraxasterol inhibits the peroxidation of egg yolk phosphatidylcholine in liposomes. Acta Facul Pharm Univ Comeniane 2007;3:70-7.  Back to cited text no. 17
    
18.
Zhang X, Xiong H, Liu L. Effects of taraxasterol on inflammatory responses in lipopolysaccharide induced RAW 264.7 macrophages. J Ethnopharmacol 2012;141:206-11.  Back to cited text no. 18
    
19.
Sangeetha KN, Shilpa K, Kumari JP, Lakshmi BS. Reversal of Dexamethasone induced insulin resistance in 3T3L1 adipocytes by 3β-Taraxerol of Mangifera indica. Int J Phytother Phytopharmacol 2013;20:213-20.  Back to cited text no. 19
    
20.
Mors WB, Nascimento MC, Pereira BM, Pereira NA. Plant natural products active against snake bite-the molecular approach. Phytochem 2000;55:627-42.  Back to cited text no. 20
    
21.
Gudaityte O, Venskutonis KK. Chemotypes of Achillea millefolium transferred from 14 different locations in Lithuania to the controlled environment. Biochem Sys Ecol 2007;35:582-92.  Back to cited text no. 21
    
22.
Saeed MT, Agarwal R, Khan MW, Ahmad F, Osman SM, Akihisa T, et al. Matsumoto. Unsaponifiable lipid constituents of ten indian seed oils. J Am Oil Chem Soc 1991;68:193-7.  Back to cited text no. 22
    
23.
Beaton JM, Spring FS, Stevenson R. Triterpenoids: Part XI, The characterisation of alnusenone. J Chem Soc 1955:2616-9.  Back to cited text no. 23
    
24.
Goad LJ, Akihisa T. Sources of sterols. Anal Sterol 1997:283-323.  Back to cited text no. 24
    
25.
Kamboj A, Saluja AK. Bryophyllum pinnatum (Lam.) Kurz: Phytochemical and pharmacological profile: A review. Phcog Rev 2009;3:364-74.  Back to cited text no. 25
  Medknow Journal  
26.
Available from: http://www.drugsfuture.com/chemdata/taraxerol.html [Last accessed on 2014 Jan 14].  Back to cited text no. 26
    
27.
Itoh T, Uetsuki T, Tamura T, Matsumoto T. Characterization of triterpene alcohols of seed oils from some species of theaceae, phytolaccaceae and sapotaceae. Lipids 1980;15:407-11.  Back to cited text no. 27
    
28.
Akihisa T, Yasukawa K, Oinuma H, Kasahara T, Yamanouchi S, Takido M, et al. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochem 1996;43:1255-60.  Back to cited text no. 28
    
29.
Yasukawa K, Matsubara H, Sano Y. Inhibitory effect of artichoke (Cynara cardunculus) carcinogenesis in mouse skin. J Nat Med 2010;64:388-91.  Back to cited text no. 29
    
30.
Mitova M, Taskova R, Popov S, Berger RG, Krings U, Handjieva N. GC/MS Analysis of Some Bioactive Constituents from Carthamus lanatus L. Verlag der Zeitschrift für Naturforschung. Tübingen 2003;58:697-703.  Back to cited text no. 30
    
31.
Rajalakshmy I, Pydi R, Kavimani S. Cardioprotective medicinal plants - A Review. Int J Pharm Inv 2011;1:24-41.  Back to cited text no. 31
    
32.
Ajay SS. Hypoglycemic Activity of Coccinia Indica (Cucurbitaceae) Leaves. Int J Pharm Tech Res 2009;1:892-3.  Back to cited text no. 32
    
33.
Wang Z, Guhling O, Yao R, Li F, Yeats TH, Rose JK, et al. Two Oxidosqualene cyclases responsible for biosynthesis of Tomato Fruit cuticular triterpenoids. Plant Physiol 2011;155:540-52.  Back to cited text no. 33
    
34.
Chauhan R, Ruby K, Dwivedi S. Golden herbs used in Piles treatment: A concise report. Int J Drug Dev Res 2012;4:50-68.  Back to cited text no. 34
    
35.
Ahmed D, Tariq SS. In vitro study of antimicrobial and antioxidant activities of methanolic extracts of leaves, fruits and bark of Ficus glomerata. Int J Med Arom Plant 2012;2:30-3.  Back to cited text no. 35
    
36.
Joseph B, Raj SJ. Pharmacological properties of Ficcus Racemosa Linn.-An Overview. Int J Pharm Sci Rev Res 2010;3:134-8.  Back to cited text no. 36
    
37.
Gawronska-Grzywacz M, Krzaczek T. Identification and determination of triterpenoids in Hieracium pilosella L. J Sep Sci 2007;30:746-50.  Back to cited text no. 37
    
38.
Ganeva Y, Chanev S, Dentchev T, Vitanova D. Triterpenoids and sterols from Hypericum perforatum. Compet Rendus De I'aca Demie Bulgare Des Sci 2003;56:4-37.  Back to cited text no. 38
    
39.
Oliveira PA, Turatti IC, Camilo D, Oliveira RD. Comparative analysis of Triterpenoids from Mikania cordifolia collected from four different locations. Braz J Pharm Sci 2006;42:548-52.  Back to cited text no. 39
    
40.
Ahmad A, Husain A, Mujeeb D, Khan D, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed 2013;3:337-52.  Back to cited text no. 40
    
41.
Stiti N, Hartmann NA. Non sterol triterpenoids as major constituents of Olea europaea. J Lipid 2012;2012:476595.  Back to cited text no. 41
    
42.
Valkoa V, Fickovab M, Pravdovab E, Nagya MD, Cziglea S. Cytotoxicity of water extracts from leaves and branches of Philadelphus coronarius L. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006;150:71-3.  Back to cited text no. 42
    
43.
Leitao F, Moreira DD, Almeida MZ, Leitao SG. Secondary metabolites from the mistletoes Struthanthus marginatus and Struthanthus concinnus (Loranthaceae) leaves. Biochem Sys Ecol 2013;48:215-8.  Back to cited text no. 43
    
44.
Singh B, Sharma MK. Anti inflammatory and antimicrobial activities of triterpenoids from Stribolanthes callosus Nees. Phytomed 2002:1-7.  Back to cited text no. 44
    
45.
Bajaj YPS. Medicinal and aromatic plants. Berlin-Heidelberg: Springer - Verlag; 1994. p. 358-69.  Back to cited text no. 45
    
46.
Yarnell E, Abascal K. Dandelion (Taraxacum officinale and T mongolicum). Int Med 2009;8:37-8.  Back to cited text no. 46
    
47.
Ryu SB, Ryu S, Lee HY. Method for Agrobacterium mediated transformation of dandelion. US 20050022267 A1. 2005.  Back to cited text no. 47
    
48.
Allen M, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004;303:1818-22.  Back to cited text no. 48
    
49.
Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Revol Cancer 2005;5:161-71.  Back to cited text no. 49
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1]


This article has been cited by
1 Taste and smell in aquatic and terrestrial environments
E. Mollo,M. J. Garson,G. Polese,P. Amodeo,M. T. Ghiselin
Nat. Prod. Rep.. 2017;
[Pubmed] | [DOI]
2 Optimization of methyl jasmonate and -cyclodextrin for enhanced production of taraxerol and taraxasterol in (Taraxacum officinale Weber) cultures
Kiran Sharma,Rasheeduz Zafar
Plant Physiology and Biochemistry. 2016; 103: 24
[Pubmed] | [DOI]
3 Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia
Khan Behlol Ayaz Ahmed,Santanu Kar Mahapatra,Mamilla R. Charan Raja,Shankar Subramaniam,Megarajan Sengan,Narendran Rajendran,Sandeep Kumar Das,Kuntal Haldar,Somenath Roy,Aravind Sivasubramanian,Veerappan Anbazhagan
RSC Adv.. 2016; 6(23): 18980
[Pubmed] | [DOI]



 

Top
   
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Biosynthetic aspects
    Limitations and ...
   Conclusion
   Acknowledgement
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed3507    
    Printed58    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    
    Cited by others 3    

Recommend this journal